Status:
COMPLETED
Diaphragmatic Exercise on Parkinson Disease
Lead Sponsor:
Universidade Metodista de Piracicaba
Conditions:
Parkinson Disease
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is the second most common neurodegenerative disease in the world, considering the central nervous system disorders that affect movement. In addition to motor impairment, the l...
Detailed Description
Parkinson's disease (PD) is the second most common neurodegenerative disease in the world, considering the central nervous system disorders that affect movement. In addition to motor impairment, the l...
Eligibility Criteria
Inclusion
- Parkinson's of both genders
- No reports of respiratory diseases and / or other previous neurological complications in the assessment form
- Residents in the metropolitan area of Belém.
Exclusion
- Patients with cognitive impairment or dementia
- Patients with previous respiratory conditions or another neurological condition.
- Patients with two consecutive absences or four absences alternating with treatment.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04108520
Start Date
July 1 2019
End Date
December 1 2019
Last Update
August 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade do Estado do Pará
Belém, Pará, Brazil, 66055-490